AnagenicsASX:AN1 EBITDA Margin % is 12.83% as of Dec. 2025. The stock has 8 warning signs investors should review. Among 1,953 Consumer Packaged Goods companies, Anagenics ranks worse than 90.07% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Anagenics's EBITDA for the
six
months ended in Dec. 2025 was A$0.27 Mil. Anagenics's Revenue for the
six
months ended in Dec. 2025 was A$2.14 Mil. Therefore, Anagenics's EBITDA margin for the quarter that ended in Dec. 2025 was 12.83%.
Anagenics (ASX:AN1) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Anagenics EBITDA Margin % Related Terms
Anagenics EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Anagenics's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:AN1 vs PG, CL, KVUE: EBITDA Margin % Comparison
For the Household & Personal Products subindustry, Anagenics's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Anagenics EBITDA Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Anagenics's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Anagenics's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Anagenics (ASX:AN1) has a EBITDA Margin % of 12.83% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Anagenics and its competitors. According to the industry distribution chart, Anagenics ranks #1759 out of 1953 companies in the Consumer Packaged Goods industry, placing it in the top 90.1%.
Is Anagenics' EBITDA Margin % too high?
Anagenics' current EBITDA Margin % is 12.83%. The Consumer Packaged Goods industry median EBITDA Margin % is 8.99. Anagenics' value of 12.83% is 42.7% above this industry median. Based on the distribution chart, Anagenics ranks #1759 out of 1953 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers.
How does Anagenics' EBITDA Margin % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Anagenics ranks #1759 out of 1953 companies for EBITDA Margin %. This places Anagenics in the lower half of its industry. The industry median EBITDA Margin % is 8.99. Anagenics' value of 12.83% is 42.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Consumer Packaged Goods company?
The median EBITDA Margin % among Consumer Packaged Goods companies is 8.99, based on 1,953 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Anagenics's current EBITDA Margin % of 12.83% is 42.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Anagenics and its competitors. For the Consumer Packaged Goods industry, the median EBITDA Margin % is 8.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Anagenics's current EBITDA Margin % is 12.83%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anagenics stock overvalued right now?
Anagenics (ASX:AN1) has a current EBITDA Margin % of 12.83%. The current EBITDA Margin % is 12.83% and 42.7% above the Consumer Packaged Goods industry median of 8.99. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Anagenics (ASX:AN1), the current EBITDA Margin % is 12.83% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Anagenics Ltd is a health wellness and beauty business servicing wholesale and retail customers through omnichannel, offering premium branded products. It develops and sells differentiated and clinically validated solutions for a range of conditions associated with aging. It includes validated consumer products to help people live longer, in good health, and with confidence. Its brands include Evolis and Uspa.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:AN1 has been successfully added to your 